Product Details
Cancidas
Caspofungin Acetate50 mg/Vial
Injection
Vial
DIN/PIN/NPN
02244265
Manufacturer
Merck Frosst Canada & Cie, Merck Frosst Canada & Co.
Formulary Listing Date
2017-08-30
Unit Price
NA
Amount MOH Pays
NA
Coverage Status
Off-Formulary Interchangeable Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
J02AX04
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02486989 | Caspofungin for Injection | 222.5000 | 222.5000 |
| 02460947 | Caspofungin for Injection | 222.0000 | 222.0000 |
| 02244265 | Cancidas | NA | NA |
LU Clinical Criteria
NOEAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – August 8, 2023 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |